Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please in Korean Patients With Coronary In-stent Restenosis

NACompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

November 30, 2016

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions
Coronary Artery Disease
Interventions
DEVICE

Paclitaxel Coated PTCA Balloon Catheter

Drug coated balloon

All Listed Sponsors
lead

Genoss Co., Ltd.

INDUSTRY

NCT04405063 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please in Korean Patients With Coronary In-stent Restenosis | Biotech Hunter | Biotech Hunter